According to the Cambridge Health Institute (CHI), “the need for a more precise, predictive approach to medicine has never been greater, as we face two fundamental crises in the biotech and pharmaceutical industries. Healthcare costs are spiraling out of control in the face of near epidemics in diabetes and Alzheimer’s disease, an aging population, and soaring costs of new technology. Moreover, the pharmaceutical industry struggles as increasing costs, patient expirations, and the demise of the blockbuster model puts a premium on innovation and efficiency.
For 16 years, CHI has tracked the growth, challenges, and opportunities in this space; and on February 25 – 27, 2009, it will host the 16th International Molecular Medicine Tri-Conference in San Francisco, California.
CommerceNet’s own Dr. Jay M. Tenenbaum will give a plenary keynote on February 25 from 8:55 – 9:40am that focuses on “Therapy Development in a Network World.”